Advancing Research & Education for Primary Immunodeficiency Disorders
Join us in transforming lives through innovative research and education for Primary Immunodeficiency Disorders (PID) and other rare genetic diseases.
.
Transformative, Innovative, Life-Changing, Hopeful.
★★★★★
Research Alliance for Primary Immunodeficiency Discoveries (RAPID)
Advancing PID Research
At the Research Alliance for Primary Immunodeficiency Discoveries, RAPID, we are committed to pioneering research in gene therapy and other novel approaches for Primary Immunodeficiency Disorders, ensuring innovative treatments and education for affected children and their families.
Our Mission and Vision
Empowering Through Research
We focus on funding genetic testing and mitochondrial health, supporting awareness and education to improve lives affected by primary immunodeficiency and other rare genetic diseases.
Primary Immunodeficiency Disorder (PID)
PID is a group of more than 400 genetic disorders that affect the immune system, making individuals more susceptible to infections and certain diseases. These conditions result from defects in the development or function of the immune system, often inherited, though some may occur sporadically.
What is PID?
Early signs of PID
Early signs of PID include recurrent infections, persistent fungal infections like oral thrush, growth issues in children, excessive cavities and dental issues, and autoimmune symptoms. A family history of immunodeficiency is also a significant indicator. These signs often appear in childhood but can be noticed later in life, warranting a healthcare consultation if multiple signs are present.
The standard treatment for Primary Immunodeficiency includes immunoglobulin replacement therapy (IVIG) and, in severe cases, Hematopoietic Stem Cell Transplantation (HSCT) or gene therapy. While these manage symptoms, exploring alternatives and cures is vital to address underlying causes, reduce lifelong treatment burdens, and improve quality of life for patients.
Advancing Treatments for PID
Funding Education and Innovative Therapies
Advancing research for Primary Immunodeficiency Disorders and rare genetic diseases through innovative gene therapy solutions and other novel approaches.
Bringing Awareness to Mitochondrial Health and Immune Strength
Mitochondrial health is crucial for immune function. Reducing non-native electromagnetic fields (EMFs) and blue light, while maximizing sunlight exposure, supports mitochondrial function, boosts vitamin D levels, and enhances immunity.
PID Education & Awareness
Providing resources and support to raise awareness about primary immunodeficiency disorders and their impact.
Funding for research initiatives aimed at developing new treatments for primary immunodeficiency and genetic diseases.
Research Initiatives
Contact Us
Reach out to us for inquiries about our research or support for Primary Immunodeficiency Disorders.
Refer to our blog and X account for the latest research on PID, Gene Therapy, and Mitochondrial Health/Immune Strength.